Found: 39
Select item for more details and to access through your institution.
686 - Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.060
- By:
- Publication type:
- Article
695 - Long-term dupilumab treatment is not associated with an increased overall risk of infections in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.069
- By:
- Publication type:
- Article
692 - Dupilumab reduces atopic dermatitis lesion severity and extent in children <12 years of age with moderate-to-severe AD: interim results from the PEDISTAD real-world registry.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.066
- By:
- Publication type:
- Article
Who Rattles the Night?
- Published in:
- 2024
- By:
- Publication type:
- Short Story
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 2, p. 163, doi. 10.1007/s40272-023-00611-9
- By:
- Publication type:
- Article
Dupilumab treatment normalizes intraepidermal nerve fiber density in patients with moderate-to-severe AD.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii12, doi. 10.1093/bjd/ljad498.016
- By:
- Publication type:
- Article
Dupilumab improves disease severity in children less than 12 years of age with moderate-severe AD: interim results from PEDISTAD real-world registry.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii13, doi. 10.1093/bjd/ljad498.017
- By:
- Publication type:
- Article
Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (FLG) mutation status.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii57, doi. 10.1093/bjd/ljad498.059
- By:
- Publication type:
- Article
Pathways to Identity: Navigating Gender-Affirming Care for Youth.
- Published in:
- Meducator, 2023, n. 44, p. 30, doi. 10.35493/medu.44.30
- By:
- Publication type:
- Article
Type 2 cytokines sensitize human sensory neurons to itch-associated stimuli.
- Published in:
- Frontiers in Molecular Neuroscience, 2023, p. 1, doi. 10.3389/fnmol.2023.1258823
- By:
- Publication type:
- Article
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 787, doi. 10.1007/s40257-023-00791-7
- By:
- Publication type:
- Article
Survival in elderly patients with breast cancer with and without autoimmune disease.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13086, doi. 10.1002/cam4.5989
- By:
- Publication type:
- Article
Scientists as Influencers: The Role of Source Identity, Self-Disclosure, and Anti-Intellectualism in Science Communication on Social Media.
- Published in:
- Social Media + Society, 2023, v. 9, n. 2, p. 1, doi. 10.1177/20563051231180623
- By:
- Publication type:
- Article
NSCLC in the Era of Targeted and Immunotherapy: What Every Pulmonologist Must Know.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 6, p. 1117, doi. 10.3390/diagnostics13061117
- By:
- Publication type:
- Article
337 Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii25, doi. 10.1093/bjd/ljac140.031
- By:
- Publication type:
- Article
Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Allergy, 2022, v. 77, n. 11, p. 3388, doi. 10.1111/all.15432
- By:
- Publication type:
- Article
Differential Susceptibility of Retinal Neurons to the Loss of Mitochondrial Biogenesis Factor Nrf1.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 14, p. N.PAG, doi. 10.3390/cells11142203
- By:
- Publication type:
- Article
Effect of Inpatient Integrative Medicine Consultation on 30-Day Readmission Rates: A Retrospective Observational Study at a Major U.S. Academic Hospital.
- Published in:
- Journal of Integrative & Complementary Medicine, 2022, v. 28, n. 3, p. 241, doi. 10.1089/jicm.2021.0155
- By:
- Publication type:
- Article
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data.
- Published in:
- Pediatric Dermatology, 2022, v. 39, n. 2, p. 187, doi. 10.1111/pde.14909
- By:
- Publication type:
- Article
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 1, p. 223, doi. 10.1007/s13555-021-00638-1
- By:
- Publication type:
- Article
Safety, feasibility, and adherence of a daily, in‐home gamma sensory stimulation therapy with the Cognito Sensory Stimulation System in Alzheimer's subjects.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056480
- By:
- Publication type:
- Article
Effects of Intensive Outpatient Integrative Medicine on Health Care Utilization on High Utilizer Patients at a Major Academic Health System.
- Published in:
- Journal of Alternative & Complementary Medicine, 2021, v. 27, n. 9, p. 803, doi. 10.1089/acm.2021.0087
- By:
- Publication type:
- Article
RPA resolves conflicting activities of accessory proteins during reconstitution of Dmc1-mediated meiotic recombination.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. 2, p. 747, doi. 10.1093/nar/gky1160
- By:
- Publication type:
- Article
MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling.
- Published in:
- Molecular & Cellular Biochemistry, 2018, v. 441, n. 1/2, p. 89, doi. 10.1007/s11010-017-3176-9
- By:
- Publication type:
- Article
Sanctioned Unemployment: The Impact of Occupational Licensing Restrictions on Ex- Offenders.
- Published in:
- Washington University Journal of Law & Policy, 2018, v. 57, p. 251
- By:
- Publication type:
- Article
Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi.
- Published in:
- African Journal of Laboratory Medicine, 2018, v. 7, n. 1, p. 1, doi. 10.4102/ajlm.v7i1.690
- By:
- Publication type:
- Article
Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM.
- Published in:
- Neurology & Therapy, 2017, v. 6, n. 2, p. 175, doi. 10.1007/s40120-017-0077-5
- By:
- Publication type:
- Article
Number Needed to Treat in Multiple Sclerosis Clinical Trials.
- Published in:
- Neurology & Therapy, 2017, v. 6, n. 1, p. 1, doi. 10.1007/s40120-017-0063-y
- By:
- Publication type:
- Article
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies.
- Published in:
- Neurology & Therapy, 2016, v. 5, n. 1, p. 45, doi. 10.1007/s40120-016-0042-8
- By:
- Publication type:
- Article
Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 3433, doi. 10.2147/OTT.S79427
- By:
- Publication type:
- Article
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0144834
- By:
- Publication type:
- Article
Small Rad51 and Dmc1 Complexes Often Co-occupy Both Ends of a Meiotic DNA Double Strand Break.
- Published in:
- PLoS Genetics, 2015, v. 11, n. 12, p. 1, doi. 10.1371/journal.pgen.1005653
- By:
- Publication type:
- Article
Comparative efficacy of switching to natalizumab in active multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2015, v. 2, n. 4, p. 373, doi. 10.1002/acn3.180
- By:
- Publication type:
- Article
Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing–remitting multiple sclerosis (RRMS).
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 1, p. 57, doi. 10.1177/1352458514537013
- By:
- Publication type:
- Article
Cloud forming potential of oligomers relevant to secondary organic aerosols.
- Published in:
- Geophysical Research Letters, 2014, v. 41, n. 18, p. 6538, doi. 10.1002/2014GL061040
- By:
- Publication type:
- Article
Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: The DEFINE study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 243, doi. 10.1177/1352458513507817
- By:
- Publication type:
- Article
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing–remitting multiple sclerosis: findings from the CONFIRM study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 253, doi. 10.1177/1352458513507818
- By:
- Publication type:
- Article
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 5, p. 1388, doi. 10.1007/s00415-012-6809-7
- By:
- Publication type:
- Article
Effects of trauma intervention on HIV sexual risk behaviors among women with co-occurring disorders in substance abuse treatment.
- Published in:
- Journal of Community Psychology, 2007, v. 35, n. 7, p. 895, doi. 10.1002/jcop.20188
- By:
- Publication type:
- Article